摘要 Clinical benign prostatic hyperplasia (BPH) is one of the most common cause of lower urinary tract symptoms and transurethral resection of prostate (TURP) has been the gold standard technique for surgical treatment of benign prostate obstruction (BPO) over the last 2 decades. Although monopolar TURP is considered a safe and effective option for surgical management of BPO, there are some disadvantages, namely bleeding, transurethral resection syndrome, incompleteness of treatment. This review aims to highlight these problems, and describe the advances in technology and techniques that have evolved to minimise such complications. With the advent of lasers and bipolar technology, as well as enucleative techniques to remove the prostatic adenoma/adenomata, the problems of bleeding, transurethral resection syndrome and incomplete treatment are significantly minimised. Monopolar TURP will likely be replaced by such technology and techniques in the near future such that transurethral surgery of the prostate remain a safe and effective option in alleviating the harmful effects of BPO.
Abstract: Clinical benign prostatic hyperplasia (BPH) is one of the most common cause of lower urinary tract symptoms and transurethral resection of prostate (TURP) has been the gold standard technique for surgical treatment of benign prostate obstruction (BPO) over the last 2 decades. Although monopolar TURP is considered a safe and effective option for surgical management of BPO, there are some disadvantages, namely bleeding, transurethral resection syndrome, incompleteness of treatment. This review aims to highlight these problems, and describe the advances in technology and techniques that have evolved to minimise such complications. With the advent of lasers and bipolar technology, as well as enucleative techniques to remove the prostatic adenoma/adenomata, the problems of bleeding, transurethral resection syndrome and incomplete treatment are significantly minimised. Monopolar TURP will likely be replaced by such technology and techniques in the near future such that transurethral surgery of the prostate remain a safe and effective option in alleviating the harmful effects of BPO.
通讯作者:
Jonathan Shunming Teo,E-mail address:jonathan.teo@mohh.com.sg.
E-mail: jonathan.teo@mohh.com.sg
引用本文:
Jonathan Shunming Teo, Yee Mun Lee, Henry Sun Sien Ho. An update on transurethral surgery for benign prostatic obstruction[J]. Asian Journal of Urology, 2017, 4(3): 195-198.
Jonathan Shunming Teo, Yee Mun Lee, Henry Sun Sien Ho. An update on transurethral surgery for benign prostatic obstruction. Asian Journal of Urology, 2017, 4(3): 195-198.
[1] Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006;49:970-8. [2] Reich O, Gratzke, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality, and early outcome of transurethral resection of the prostate:a prospective multicentre evaluation of 10,654 patients. J Urol 2008;180:246-9. [3] Mebust WK, Holtgrewe HL, Cockett AT, Peters PC, Writing Committee, the American Urological Association. Transurethral prostatectomy:immediate and postoperative complications. Cooperative study of 13 participating institutions evaluation 3885 patients. J Urol 1989;141:243-7. [4] Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)dincidence, management and prevention. Eur Urol 2006;50:969-80. [5] Lynch M, Sriprasad S, Subramonian K, Thompson P. Postoperative haemorrhage following transurethral resection of the prostate (TURP) and photoselective vaporisation of the prostate (PVP). Ann R Coll Surg Engl 2010;92:555-8. [6] Tan L, Venkatesh SK, Consigliere D, Heng CT. Treatment of a patient with post-TURP haemorrhage using bilateral SAPE. Nat Rev Urol 2009;6:680-5. [7] Rehman J, Khan SA, Sukkarieh T, Chughtai B, Waltzer WC. Extraperitoneal laparoscopic prostatectomy (adenomectomy) for obstructing benign prostatic hyperplasia:transvesical and transcapsular (Millin) techniques. J Endourol 2005;19:491-6. [8] Sotelo R, Spaliviero M, Garcia-Segui A, Hasan W, Novoa J, Desai MM, et al. Laparoscopic retropubic simple prostatectomy. J Urol 2005;173:757-60. [9] Lim KB, Wong MY, Foo KT. Transurethral resection of prostate (TURP) through the decadesda comparison of results over the last thirty years in a single institution in Asia. Ann Acad Med Singap 2004;33:775-9. [10] Wendt-Nordahl G, Häcker A, Reich O, Djavan B, Alken P, Michel MS. The Vista system:a new bipolar resection device for endourological procedures:comparison with conventional resectoscope. Eur Urol 2004;46:586-90. [11] Engeler DS, Schwab C, Neyer M, Grün T, Reissigl A, Schmid HP. Bipolar versus monopolar TURP:a prospective controlled study at two urology centers. Prostate Cancer Prostatic Dis 2010;13:285-91. [12] Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate:a systematic review and meta-analysis of randomized controlled trials. Eur Urol 2009;56:798-809. [13] Fagerström T, Nyman CR, Hahn RG. Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique:a single-centre randomized trial of 202 patients. BJU Int 2009;105:1560-4. [14] Elmansy HM, Kotb A, Elhilali MM. Holmium laser enucleation of the prostate:long-term durability of clinical outcomes and complication rates during 10 years of follow-up. J Urol 2011; 186:1972-6. [15] Gilling PJ, Aho TF, Framptom CM, King CJ, Fraundorfer MR. Holmium laser enucleation of the prostate:results at 6 years. Eur Urol 2008;53:744-9. [16] Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation:an update on the early clinical experience. J Endourol 1998;12:457-9. [17] Madsen PO, Madsen RE. Clinical and experiment evaluation of different irrigating fluids for transurethral surgery. Invest Urol 1965;3:122-9. [18] Ekengren J, Zhang W, Hahn RG. Effects of bladder capacity and height of fluid bag on intravesical pressure during transurethral resection of the prostate. Eur Urol 1995;27:26-30. [19] Hagn RG. Irrigating fluids in endoscopic surgery. Br J Urol 1997;79:669-80. [20] Moorthy HK, Philip S. TURP syndrome e current concepts in the pathophysiology and management. Indian J Urol 2001;17:97-102. [21] Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW. A prospective randomised study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 2007;52:517-24. [22] Gilleran JP, Thaly RK, Chernoff AM. Rapid communication:bipolar PlasmaKinetic transurethral resection of the prostate:reliable training vehicle for today's urology residents. J Endourol 2006;20:683-7. [23] Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ. Transurethral resection of the prostate among Medicare beneficiaries:1984 to 1997. For the patient outcomes research team for prostatic diseases. J Urol 2000;164:1212-5. [24] Madersbacher S, Kackner J, Brossner C, Rohlich M, Stancik I, Willinger M, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy:a nation-wide, long term analysis of 23,123 cases. Eur Urol 2005;47:499-504. [25] Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Eng J Med 1989;320:1120-4. [26] Liu C, Zheng S, Li H, Xu K. Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 2010;184:2440-5. [27] Wei Y, Xu N, Chen SH, Li XD, Zheng QS, Lin YZ, et al. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60 gr:a retrospective study at a single academic tertiary care center. Int Braz J Urol 2016;42:747-56. [28] Zhao Z, Zeng G, Zhong W, Mai Z, Zeng S, Tao X. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia:three-year follow-up results. Eur Urol 2010;58:752-8. [29] Xie L, Mao Q, Chen H, Qin J, Zheng X, Lin Y, et al. Transurethral vapor enucleation of the prostate with plasma vaporization button electrode for the treatment of benign prostatic hyperplasia:a feasibility study. J Endourol 2012;26:1264-6. [30] Taher A. Erectile dysfunction after transurethral resection of prostate:incidence and risk factors. World J Urol 2004;22:457-60. [31] Choi SB, Zhao C, Park JK. The effect of transurethral resection of the prostate on erectile function in patients with benign prostatic hyperplasia. Korean J Urol 2010;51:557-60. [32] Pavone C, Abbadessa D, Scaduto G, Caruana G, Scalici Gesolfo C, Fontana D, et al. Sexual dysfunctions after transurethral resection of the prostate (TURP):evidence from a retrospective study of 264 patients. Arch Ital Urol Androl 2015;87:8-13. [33] Hogewoning CR, Meij LA, Pelger RC, Putter H, Krouwel EM, Elzevier HW. Sling surgery for the treatment of urinary incontinence after transurethral resection of the prostate:new data on the Virtue male sling and an evaluation of literature. Urology 2017;100:187-92. [34] Sundaram P, Kuo TLC, Cheng CWS, Foo KT. Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate. Singap Med J 2016;57:676-80.
Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26
-32
.
